Research Progress of Drugs for the Treatment of Gout
DOI:
https://doi.org/10.54097/ijbls.v4i3.11Keywords:
Gout, Uric Acid, TreatmentAbstract
Gout is directly related to hyperuricemia caused by purine metabolism disorder and/or reduced uric acid excretion, and belongs to the category of metabolic rheumatism. Currently, there are many drugs on the market for the treatment of hyperuricemia and gout, but most of them are chemical synthetic drugs. The main direction of chemical drugs targeted at gout attacks is to inhibit enzyme action or use hormones to relieve pain during gout attacks, and control cytokine/inflammatory cell movement and function to reduce inflammatory response. The treatment in interphase and chronic phase is mainly uric acid lowering treatment. The chemical drugs used to reduce uric acid are mainly divided into three categories: inhibiting the synthesis of uric acid, promoting the excretion of uric acid and promoting the decomposition of uric acid. However, at present, the therapeutic effect of traditional Chinese medicine and biological drugs is gradually obvious. This paper mainly reviews the shortcomings of chemical drugs, traditional Chinese medicine and drug use in the treatment of gout and hyperuricemia, aiming to provide reference for the clinical treatment of hyperuricemia and gout.
Downloads
References
Jiang Ming, David Y U, Lin Xiaoyi, et al. Chinese Rheumatology [M]. Beijing: Huaxia Publishing House, 2004: 1221-1223.
Huo Shuai. Blood metabolomics analysis of patients with hyperuric acid nephropathy and experimental study on Shencha treatment of hyperuric acid nephropathy [D]. Guangzhou University of Chinese Medicine, 2020.
ZHAO R. Study on the effect and mechanism of black tea in relieving gout symptoms [D]. Hunan Agricultural University, 2017. (in Chinese)
Liang Danling. Study on the effect of Ganoderma lucidum and Tuckaia extract on hyperuricemia [D]. Guangzhou University of Traditional Chinese Medicine, 2019.
Cheng Liangfeng, Lu Jinming. New progress of drug therapy for gout [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(09):1066-1071. (in Chinese)
TAN C. Experimental study on serum uric acid OAT1 and URAT1 mRNA expression of mouse kidney uric acid transporter proteins involved in hyperuricemia model of Dixiebubi Decoction [D]. Nanjing University of Chinese Medicine, 2014.
Ye Wenjing. Animal experimental study of Jianpi Xiaoshi Jiedu Decoction in the treatment of hyperuricemia [D]. Guangzhou University of Traditional Chinese Medicine, 2021.
SHEN Linqiang, Deng Xinjie, ZHANG Shuwei, Xu Sijie, Li Dong, Liu Biyuan. The pathogenesis of hyperuricemia and gout and the intervention effect of Chinese medicine [J]. Chinese Folk Therapy, 201, 29(15):120-125. (in Chinese)
YAN Hui, LAN Jinshan, PU Zongjin, Guo Sheng, Li Simeng, Zhou Guisheng, Chen Peidong, ZHAN Zhilai, Duan Jin. Research progress on chemical constituents and pharmacological activities of Plum Blossom [J]. Chinese Herbal Medicine, 2019, 52(11):3453-3461. (in Chinese)
Zheng Xiaowei, Xia Daozong, Zhang Ying. Inhibitory effect of total flavonoids of plum blossom on xanthine oxidase and its antioxidant activity [J]. Science and Technology of Food Industry, 2011,32 (11):168-170+173.
WEI Zhilin, Zhang Jie, Li Huanan, Wu Jianfeng, LIU Yongqian, Gu Bing. Overview of the mechanism of uric acid lowering by single Chinese medicine [J]. Chinese Medicine Bulletin, 201, 20(06):69-72. (in Chinese)
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
